❌

Normal view

There are new articles available, click to refresh the page.

Before yesterdayMain stream

TechCrunch
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation 20 July 2026 at 19:39

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

By: Marina Temkin

20 July 2026 at 19:39

The de-extinction startup is looking to double or triple its previous valuation, according to the report.